American Association for Cancer Research
Browse
23266066cir170081-sup-178787_2_supp_4096559_nrgqh8.png (555.11 kB)

Figure S2 from Modulation of Endoplasmic Reticulum Stress Controls CD4+ T-cell Activation and Antitumor Function

Download (555.11 kB)
figure
posted on 2023-04-03, 23:21 authored by Jessica E. Thaxton, Caroline Wallace, Brian Riesenberg, Yongliang Zhang, Chrystal M. Paulos, Craig C. Beeson, Bei Liu, Zihai Li

Efficient deletion of gp96 in CD4creHsp90b1flox/flox mice and assessment of TCRvβ chains

Funding

NIH

Hollings Cancer Center's K12

History

ARTICLE ABSTRACT

The endoplasmic reticulum (ER) is an energy-sensing organelle with intimate ties to programming cell activation and metabolic fate. T-cell receptor (TCR) activation represents a form of acute cell stress and induces mobilization of ER Ca2+ stores. The role of the ER in programming T-cell activation and metabolic fate remains largely undefined. Gp96 is an ER protein with functions as a molecular chaperone and Ca2+ buffering protein. We hypothesized that the ER stress response may be important for CD4+ T-cell activation and that gp96 may be integral to this process. To test our hypothesis, we utilized genetic deletion of the gp96 gene Hsp90b1 in a CD4+ T cell–specific manner. We show that gp96-deficient CD4+ T cells cannot undergo activation-induced glycolysis due to defective Ca2+ mobilization upon TCR engagement. We found that activating naïve CD4+ T cells while inhibiting ER Ca2+ exchange, through pharmacological blockade of the ER Ca2+ channel inositol trisphosphate receptor (IP3R), led to a reduction in cytosolic Ca2+ content and generated a pool of CD62Lhigh/CD44low CD4+ T cells compared with wild-type (WT) matched controls. In vivo IP3R-inhibited CD4+ T cells exhibited elevated tumor control above WT T cells. Together, these data show that ER-modulated cytosolic Ca2+ plays a role in defining CD4+ T-cell phenotype and function. Factors associated with the ER stress response are suitable targets for T cell–based immunotherapies. Cancer Immunol Res; 5(8); 666–75. ©2017 AACR.

Usage metrics

    Cancer Immunology Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC